## TXN: Texas Instruments Incorporated - XLK: Technology

### Executive Summary

No thesis match: MRS_10 2.1% below STRENGTH zone (3.0-6.0%); PEG 1.56 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($169.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Fayez Sarofim & Co Sells 192,885 Shares of Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251209T110925 | Neutral | Relevance: 99%
-  Fayez Sarofim & Co has reduced its stake in Texas Instruments Incorporated ($TXN) by selling 192,885 shares, decreasing its holdings by 4.1% in the second quarter. Despite the sale, Texas Instruments remains the 12th largest position for Fayez Sarofim & Co, accounting for approximately 2.2% of its total holdings. The article also notes other institutional investor activities, insider trading, and recent analyst ratings for TXN, highlighting a consensus "Hold" rating with a target price of $191.67.

**2. Natixis Sells 114,096 Shares of Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251208T130848 | Neutral | Relevance: 99%
-  Natixis reduced its stake in Texas Instruments Incorporated by 38.2% in the second quarter, selling 114,096 shares and now holding 184,841 shares valued at $38.38 million. Texas Instruments reported in-line EPS and raised its quarterly dividend, while several analysts lowered price targets and the consensus rating is "Hold". Other institutional investors also adjusted their positions in the semiconductor company.

**3. Ossiam Sells 17,762 Shares of Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251208T115552 | Neutral | Relevance: 98%
-  Ossiam reduced its stake in Texas Instruments Incorporated (NASDAQ:TXN) by 5.7% in the second quarter, selling 17,762 shares and holding 293,981 shares valued at $61,036,000. Several other institutional investors also adjusted their holdings in Texas Instruments, and Wall Street analysts have issued various ratings and price targets for the semiconductor company. Texas Instruments recently announced an increased quarterly dividend of $1.42 per share and reported quarterly earnings that hit analyst consensus estimates.

**4. Who Owns Texas Instruments? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251207T140913 | Bullish | Relevance: 98%
-  This article examines the major shareholders and recent insider trading activity of Texas Instruments (NASDAQ: TXN), a leading analog semiconductor company. It details the substantial holdings by large passive institutional investors like Vanguard and BlackRock, highlights significant increases in stakes by several hedge funds, and reviews recent small-scale insider transactions. The analysis indicates that while passive institutions provide long-term stability, active managers show mixed expectations, and insider activity largely comprises administrative entries rather than major shifts in sentiment.

**5. Lansdowne Partners UK LLP Has $6.09 Million Position in Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251208T123645 | Somewhat-Bullish | Relevance: 98%
-  Lansdowne Partners UK LLP increased its stake in Texas Instruments Incorporated (NASDAQ:TXN) by 68.1% in the second quarter, bringing their total holdings to 29,338 shares valued at $6.09 million. Other institutional investors also significantly adjusted their positions in Texas Instruments. The company recently announced a quarterly dividend increase to $1.42 per share, and analysts have a consensus "Hold" rating on the stock with a target price of $191.67.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($0.58M) |
| Sells | 4 ($0.52M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.6% (+1.1%)
- Blackrock Inc.: 8.5% (+0.1%)
- JPMORGAN CHASE & CO: 6.0% (+80.5%)
- State Street Corpora: 4.8% (+0.5%)
- Charles Schwab Inves: 2.5% (+3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.56 elevated, pricing in significant growth expectations. Forward P/E 29.2x stretched relative to 12% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 29%). Balance sheet: strong liquidity (4.5x). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $163.2B |
| Beta | 0.99 |
| 52W Range | $139.95 - $221.69 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.56 |
| Forward P/E | 29.2 |
| Current P/E | 32.8 |
| YoY Growth | 12.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 8.2% to 2.1% (-6.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.9pp (needs >3.0% for momentum thesis). MRS_5 (-1.1%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (2.63), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.14% (CS: 78) | Neutral |
| RSI_14 | 63.4 | Neutral |
| MACD Histogram | 2.63 | Bullish |
| vs SMA20 | 1.077x | Above |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 0.985x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $179.52
- **Stop Loss:** $169.74 (5.4% risk)
- **Target:** $189.30 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 122
- **Position Value:** $21,901.44
- **Portfolio %:** 21.90%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-20 (Est: $1.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.49 | $1.48 | -0.4% |
| 2025Q2 | $1.33 | $1.41 | +5.8% |
| 2025Q1 | $1.06 | $1.28 | +20.2% |
| 2024Q4 | $1.20 | $1.30 | +8.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*